Plasma Free mtDNA and Expression of TLR-9/MAPK in Brain Tissues of Rats with Subarachnoid Hemorrhage
Abstract
To determine the plasma level of mitochondrial DNA (mtDNA) and the expression of Toll like receptor-9/mitogen-activated protein kinase (TLR-9/MAPK) in the brain tissues of rats with subarachnoid hemorrhage (SAH). Methods Sprague-Dawley rats were used to establish SAH models with a modified method of endovascular perforation. Twenty four hours after the establishment of the models, the plasma level of mtDNA in the rats was detected by real-time PCR; the expressions of TLR-9 and P38 MAPK in the brain tissues were detected by reverse transcription PCR (RT-PCR) and immunohistochemical staining. Differences between the SAH (n =20) and sham-surgical (n =20) groups were compared. Results Rats in the SAH group had higher levels of plasma mtNDA and expressions of TLR-9 and P38 MAPK in brain tissues than those in the sham-surgical group (P <0.05). Conclusion Plasma free mtDNA and expressions of TLR-9/MAPK increase simultaneously in rats with SAH. mtDNA may induce system and local inflammation reactions in brain.
Keywords: Subarachnoid hemorrhage (SAH), Early brain injury (EBI), Mitochondrial, DNA (mtDNA), Toll like receptor-9 (TLR-9), Mitogen-activated protein kinase (MAPK)
Full Text:
PDFReferences
PROVENCIO JJ. Inflammation in subarachnoid hemorrhage and delayed deterioration associated with vasospasm: a review. Acta Neurochir Suppl.2013 ,115 ;233-238.
WANG HC, YANG TM. LIN WC, et al. The value of serial plasma and cerebrospinal fluid nuclear and mitochondrial deoxyribonucleic acid levels in aneurysmal subarachnoid hemorrhage. J Neurosurg,2013 ,118( 1): 13-19.
ZHANG Q. RAOOF M, CHEN Y, et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature,2010.464(7285): 104-107.
MALIK AN, SHAHNI R. RODRIGUEZ-DE-LEDESMA A, et al. Mitochondrial DNA as a non-invasive biomarker: accurate quantification using real time quantitative PCR without co-amplification of pseudogenes and dilution bias. Biochem Biophs Res Commun,2011,412(1): 1-7.
YATSUSHIGE H, CALVERT JW, CAHILL J, et al. Limited role of inducible nitric oxide synthase in blood-brain barrier function after experimental subarachnoid hemorrhage. J Neurotrauma,2006,23( 12): 1874-1882.
GARG АГ), NOWIS D, GOLAB J, et al. Immunogenic cell death, DAMPs and anticancer therapeutics; an emerging amalgamation. Biochim Biophys Acta,2010,1805( 1):53-71. LAM NY, RAINER TH, WONG LK, et al. Plasma DNA as a prognostic marker for stroke patients with negative neuroimaging within the first 24 h of symptom onset. Resuscitation,2006,68( 1);71-78.
CAVELIER L. JOHANNISSON A, GYLLENSTEN U. Analysis of mtDNA copy number and composition of single mitochondrial particles using flow cytometry and PCR. Exp Cell Res,2000,259( 1) ;79-85.
ZHANG Q, ITAGAKI K. HAUSER CJ. Mitochondrial DNA is released by shock and activates neutrophils via p38 map kinase. Shock,2010,34(1):55-59.
WEST AP, SHADEL GS, GHOSH S. Mitochondria in innate immune responses. Nat Rev Immunol - 2011, 11 (6): 389-402.
WALKO TD 3rd, BOLA RA, HONG JD, et al. Cerebrospinal fluid mitochondrial DNA; a novel DAMP in pediatric traumatic brain injury. Shock, 2014 , 41 ( 6 ); 499- 503.
DHAR R, DIRINGER MN. The burden of the systemic inflammatory response predicts vasospasm and outcome after subarachnoid hemorrhage. Neurocrit Care, 2008, 8 ( 3 ); 404- 412.
WEST AP, KOBLANSKY AA, GHOSH S. Recognition and signaling by toll-like receptors. Annu Rev Cell Dev Biol, 2006,22 ;409-437[2016-04-10 . http://www. annualreviews. org/doi/10. 1146/annurev. cellbio. 21. 122303. 115827.
LEE SH, LEE JG, KIM JR, et al. Toll-like receptor 9- mediated cytosolic phospholipase A2 activation regulates expression of inducible nitric oxide synthase. Biochem Biophys Res Commun, 2007,364(4);996-1001.
MACX, YIN WN, CAI BW, et al. Toll-like receptor4/ nuclear factor-kappa b signaling detected in brain after early subarachnoid hemorrhage. Chin Med J (Engl), 2009, 122 (13): 1575-1581.
HUGLE M. FULDA S. Dual phosphatidylinositol 3-kinase/ mammalian target of rapamycin inhibitor nvp-BEZ235 synergizes with chloroquine to induce apoptosis in embryonal rhabdomyosarcoma. Cancer Let ,2015, 360( 1): 1-9.
RODRIK-OUTMEZGUINE VS, CHANDARLAPATY S, PAGANO NC, et al. mTOR kinase inhibition causes feedback-dependent biphasic regulation of АКТ signaling. Cancer Discov,2011,1(3) :248-259.
SONENBERG N, HINNEBUSCH AG. Regulation of translation initiation in eukaryotes;mechanisms and biological targets. Cell. 2009,136(4 ); 731-745.
CHANG F, LEEJT. NAVOLANIC PM. Et al. Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy. Leukemia, 2003 ,17(3) ; 590-603.
LIU P, CHENG H, ROBERTS TM, et al. Targeting the phosphoinositide 3-kinase pathway in cancer. Nat Rev Drug Discov,2009,8(8) ;627-644.
TASIAN SK. TEACHEY DT, RHEINGOLD SR. Targeting the Pl3K/mTOR pathway in pediatric hematologic malignancies. Front Oncol, 2014 ( 4 ): 108 [2016-03-08]. https;//www. ncbi. nlm. nih. gov/pmc/articles/pmid/ 24904824/. doi: 10. 3389/fonc. 2014. 00108.
CHEN YL, LAW PY, LOH HH. Inhibition of PI3K/Akt signaling:an emerging paradigm for targeted cancer therapy. Curr Med Chem Anti-cancer Agents,2005,5(6):575-589.
SCHOLLS, BONDEVA T, LIU Y. et al. Additive effects of Pl3-kinase and МАРК activities on NBl cell granulocyte differentiation; potential role of phosphatidylinositol 3-kinase gamma. J Cancer Res Clin Oncol.2006,134(8);861 -872.
Refbacks
- There are currently no refbacks.
